Erythropoietin, a potent angiogenic factor induced by ischemia, appears at higher concentrations in the eyes of patients with diabetic macular edema compared to those with age-related macular degeneration (AMD) or non-diabetic individuals [296]. Here, EPO is linked to age-related macular degeneration.